Dr. Maher M. Rabah, DO

Dr. Rabah practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Rabah's NPI, 1013967793, was assigned on May 11, 2006. Dr. Rabah graduated from Kansas City University of Med & Biosciences, College of Osteo Med in 1989. Dr. Rabah holds Michigan license 5101010738.

Dr. Rabah's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Rabah's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Rabah is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Rabah to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rabah practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Rabah's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Rabah is licensed in Michigan.

CMS data shows 2,264 Medicare services from Dr. Rabah across 18 procedure codes in 2024, for 825 Medicare patients. Medicare paid $151,061 for them.

CMS counts 825 Medicare patients who saw Dr. Rabah in 2024. The largest group is 75 to 84, with 340 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rabah's median patient age at 70, with 43% women.

In 2024, Dr. Rabah wrote 10,827 Medicare Part D claims for 1,107 patients. 84% of them were for generic drugs. CMS names the drug for 10,523 of them, across 73 drugs with 11 or more claims each, at $1,740,283 in total drug cost. In 2023, CMS named 10,332 claims across 73 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Rabah for performance year 2024, reported as part of a group. Dr. Rabah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rabah as offering telehealth. CMS counts 55 procedures of coronary angioplasty and stenting by Dr. Rabah, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Rabah, published from 2019 to 2022. The most frequent topics are Cardiac Catheterization, Occupational Exposure and Radiation Dosage. Dr. Rabah's most frequent co-authors are Amr E. Abbas, MD, Sorcha Allen, MB, BCH, BAO and Aaron D. Berman, MD.

CMS Open Payments shows 96 general payments to Dr. Rabah from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. Boston Scientific Corporation paid the most, $2,655.

Dr. Rabah graduated from Kansas City University of Med & Biosciences, College of Osteo Med in 1989.